Self-developed and patented innovations in m-health

Brighter

Brighter AB is a Swedish company that develops medical devices to treat diseases with a high unmet need. Its lead product in development is Actiste, for diabetes management.

Financials

Brighter

SEKm 2017 2018 2019
Sales 1 0 3
Sales growth (%) -58,3 -100 0
EBITDA -50 -61 -56
EBITDA margin (%) -3609,3 0 -1783,9
EBIT adj -50 -65 -67
EBIT adj margin (%) -3609,3 0 -2110,2
Pretax profit -57 -67 -69
EPS rep -1,33 -1,12 -1,28
EPS growth (%) -17,7 15,9 -15,1
EPS adj -1,33 -1,12 -1,28
DPS 0 0 0
EV/EBITDA (x) -13 -10,6 -11,1
EV/EBIT adj (x) -13 -9,9 -9,4
P/E (x) -7,6 -9,2 -8
P/E adj (x) -7,6 -9,2 -8
EV/sales (x) 470,5 0 197,6
FCF yield (%) -11,4 -8,8 -5,8
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 0 0,3 0,8

Main shareholders

Brighter

Main shareholders Share capital % Voting shares %
Avanza Pension 13.5 % 13.5 %
Truls Sjöstedt 8.9 % 8.9 %
Michael Göran Erik Frantzén 7.1 % 7.1 %
Jonas Metzger 1.6 % 1.6 %
Minh Nguyen 1.4 % 1.4 %
Robert Mellin 1.3 % 1.3 %
Swedbank Försäkring 1.2 % 1.2 %
Nordnet Pensionsförsäkring 1.2 % 1.2 %
Henrik Norström 0.9 % 0.9 %
Livförsäkringsbolaget Skandia 0.9 % 0.9 %